Gwangju, South Korea

Chan Kim

USPTO Granted Patents = 60 

 

Average Co-Inventor Count = 3.1

ph-index = 6

Forward Citations = 99(Granted Patents)

Forward Citations (Not Self Cited) = 94(Oct 12, 2025)


Location History:

  • Gwangju-si, KR (2013)
  • Osan-si, KR (2023)
  • Gimpo-si, KR (2023)
  • Daejeon, KR (2023)
  • Seoul, KR (2008 - 2024)
  • Hwaseong-si, KR (2009 - 2024)
  • Gwangju, KR (2013 - 2024)

Company Filing History:

goldMedal23 out of 131,214 
 
Samsung Electronics Co., Ltd.
 patents
silverMedal12 out of 172 
 
Amogreentech Co., Ltd.
 patents
bronzeMedal7 out of 28 
 
Amolifescience Co., Ltd.
 patents
44 out of 2,607 
 
Korea Advanced Institute of Science and Technology
 patents
53 out of 477 
 
Samsung Medison Co., Ltd.
 patents
62 out of 96 
 
Konkuk University Industrial Cooperation Corp
 patents
72 out of 3 
 
Kollodis Biosciences, Inc.
 patents
82 out of 419 
 
Korea Institute of Energy Research
 patents
92 out of 471 
 
Gwangju Institute of Science and Technology
 patents
102 out of 2 
 
Curocell, Inc.
 patents
111 out of 49,601 
 
Lg Electronics Inc.
 patents
121 out of 1,557 
 
Seoul National University
 patents
131 out of 1 
 
Amomedi Co., Ltd.
 patent
141 out of 1 
 
Medi Bio Lab. Co., Ltd.
 patent
151 out of 1,131 
 
Korea University Research and Business Foundation
 patents
161 out of 2,626 
 
Hyundai Mobis Co., Ltd.
 patents
171 out of 1 
 
Altsoft. Inc.
 patent
181 out of 2 
 
Korea Institute for Knit Industry
 patents
191 out of 11 
 
Korea Institute of Medical Microrobotics
 patents
202 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2008-2025

Loading Chart...
Loading Chart...
60 patents (USPTO):

Title: Innovations of Chan Kim: Pioneering Advances in Cell Culture and Tissue Engineering

Introduction

Chan Kim, an accomplished inventor based in Gwangju, South Korea, holds an impressive portfolio of 48 patents. His groundbreaking work primarily focuses on innovations in cell culture scaffolds and materials for tissue engineering, contributing significantly to advancements in medical and biotechnological fields.

Latest Patents

Among his most recent patents, Chan Kim developed a "Yarn for Cell Culture Scaffold, Ply Yarn Comprising Same and Fabric Comprising the Same." This innovative yarn features multiple twists created by twisting single or multiple fiber strands, along with fiber grooves that form three-dimensional growth spaces and migration paths for cells. This design enhances cell proliferation rates and cell viability by mimicking microenvironments conducive to cell growth and differentiation. Moreover, the scaffold allows for the formation of uniform cell clusters, making it viable for use in in vitro experimental models and potential transplantation into animal bodies, thereby broadening its application in cell culture and tissue engineering.

Another notable patent is the "Nanofiber Composite Membrane for Guided Bone Regeneration, and Manufacturing Method Therefor." This patent details a method for producing a nanofiber composite membrane through electrospinning, which includes steps to ensure the membrane's biocompatibility and maintain its physical properties. The incorporation of a biocompatible plasticizer helps to retain flexibility and prevent brittleness during sterilization, making it an important development for guided bone regeneration applications.

Career Highlights

Chan Kim has made significant contributions through his work with renowned companies, including Samsung Electronics and Amogreentech. His expertise in material science and bioengineering has solidified his reputation as a key innovator in the industry.

Collaborations

Throughout his career, Chan Kim has collaborated with esteemed colleagues such as Seung Hoon Lee and In Yong Seo. Their combined expertise and innovative spirit have furthered the development of cutting-edge technologies in cell culture and tissue engineering.

Conclusion

Chan Kim is an exemplary inventor whose patents reflect a commitment to innovation in biotechnology and materials science. His latest developments in cell culture scaffolds and nanofiber membranes demonstrate significant potential for advancing medical research and applications, ultimately benefiting the field of tissue engineering and regenerative medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…